Elucidation of the biliary secretion machinery Ronald Oude Elferink Invited Commentary Pages: 439 - 440
The role of cyclooxygenase selective inhibitors in the gastrointestinal tract Byron Cryer OriginalPaper Pages: 453 - 458
Helicobacter and gastric cancer disease mechanisms: Host response and disease susceptibility Hanchen LiCalin StoicovJeanMarie Houghton OriginalPaper Pages: 459 - 467
Advances in the management of irritable bowel syndrome Brooks D. CashWilliam D. Chey OriginalPaper Pages: 468 - 475
Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding Shireen Andrade PaisRussell Yang OriginalPaper Pages: 476 - 481
Genetic and pathogenetic insights into inflammatory bowel disease Francesco PalloneGiovanna Del Vecchio BlancoGiovanni Monteleone OriginalPaper Pages: 487 - 492
Recent advances in the diagnosis and classification of inflammatory bowel disease Eric Vasiliauskas OriginalPaper Pages: 493 - 500
Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease William J. Sandborn OriginalPaper Pages: 501 - 505
Optimizing immunomodulator therapy for inflammatory bowel disease Marla C. Dubinsky OriginalPaper Pages: 506 - 511
Extraintestinal complications of inflammatory bowel disease Tim Orchard OriginalPaper Pages: 512 - 517
Future therapies for inflammatory bowel disease Stephen J. BickstonLawrence W. ComerfordFabio Cominelli OriginalPaper Pages: 518 - 523